Immunic, Inc.
IMUX
$0.8293
-$0.0229-2.69%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.29% | -1.18% | -3.31% | -13.98% | 27.73% |
| Total Depreciation and Amortization | 0.00% | 22.86% | -16.67% | 35.48% | 19.23% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -6.73% | -0.52% | 7.12% | 26.11% | -84.02% |
| Change in Net Operating Assets | -86.27% | 2,095.77% | -95.44% | -43.40% | 166.05% |
| Cash from Operations | -13.01% | 5.17% | -10.38% | -22.09% | 28.91% |
| Capital Expenditure | 23.40% | -1,466.67% | 94.00% | 72.22% | -480.65% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 23.40% | -1,466.67% | 94.00% | 72.22% | -480.65% |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -100.00% |
| Foreign Exchange rate Adjustments | -71.02% | 189.30% | -327.43% | 157.22% | -327.01% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 291.94% | 8.71% | -13.46% | -17.11% | -134.78% |